News

Despite 90% of patients who participated in a TrialJectory survey acknowledging importance of genetic testing, less than half have undergone next-generation sequencing.

The therapy is the first approved for patients with tumors associated with von Hippel-Lindau disease.

Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.

Duplication and other errors can turn population health into a guessing game and waste time and money.

Screening and vaccination against HPV have reduced the incidence of cervical cancer, but researchers say some women are being screened for cervical caner too often — partly because of vaccination.

An estimated 1-6% of all children and adolescents have obstructive sleep apnea.

The first half of 2021 saw 372 deals averaging $39.6 million, which is already more than the total value of the deals done in all of 2020.

Positive trial results were reported in The Lancet last year. The FDA is scheduled (the PDUFA date) to make a decision on the application for approval early next year.

Three differentiators that separate leaders from chasers in virtual health transformation.

Many people ignored heart disease signs and symptoms during the COVID-19 pandemic — sometimes with grave consequences.

The multiple myeloma therapy now has a permanent J code under Medicare Part B.

Healthcare organization serving 3.5 million people in communities throughout mid-Atlantic region announces vaccine requirement for workforce, board members and guests.

Trials result show that Lyumjev compares favorably to Humalog.

In this second part of a two-part video series, Briana Contreras, associate editor of MHE caught up with MHE Editorial Advisory Board member David Calabrese, who is market president of Health Plans/PBMs at OptumRx. Calabrese shared his thoughts on the approval of the Alzheimer’s drug Aduhelm, as well as the Biden Administration's interest in putting more generics and biosimilars in the market.

FDA approval of Lumakras was contingent on a trial testing lower doses. It could usher in a new era of optimal dosing instead of the maximum tolerated dosing.

In this part one video, Briana Contreras, associate editor of MHE caught up with MHE Editorial Advisory Board member David Calabrese, who is market president of Health Plans/PBMs at OptumRx. Calabrese shared his thoughts on the approval of the Alzheimer’s drug Aduhelm, as well as the Biden Administration's interest in putting more generics and biosimilars in the market.

Another FDA approval and two additional applications for Keytruda have been submitted; a generic for Chantix and a sleep disorder treatment is approved; and a complete response letter has been issued for an anemia therapy.

New interoperability rules will soon empower individuals to access healthcare data from their smartphone.

The confirmatory trial of one of the approved drugs, Pepaxto, was halted when data suggested it was associated with a higher mortality rate.

This is the first approval of generic version of Chantix, and it comes just weeks after a recall of the brand-name drug.

Accelerated approval and use of surrogate markers are among the friction points. But some see the OK as spawning a new generation of drug development for treating Alzheimer’s disease.

The potassium-lowering agent was associated with a 20% relative reduction in costs related to outpatient, inpatient, and emergency department visits.

To fully leverage SDOH information and provide more complete services throughout the care continuum in support of value-based care, payers should include community-based organizations (CBOs) in their value-based care network contracting strategies. Doing so creates a broadened, higher performing set of resources to keep people healthy and at home.

The VA recommends against offering this agent to patients with Alzheimer’s dementia, mild or otherwise.

At this time, two of three conferences have been reverted to a in-person and virtual format. This includes The American Urological Association (AUA) 2021 Annual Meeting and the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting.

Everything from the amount of daylight in a room to the timing of vital sign checks during the night can influence the sleep of patients in intensive care units and thus their recovery.

In this week's episode, editors of Managed Healthcare Executive, Peter Wehrwein and Briana Contreras caught up with MHE Editorial Advisory Board member David Calabrese, market president of Health Plans/PBMs at OptumRx, for another segment of the Meet the Board series. The three discussed Calabrese’s career history, his personal wellbeing lifestyle, and his thoughts on the approval of the Alzheimer’s drug Aduhelm, as well as the Biden Administration's interest in putting more generics and biosimilars in the market.

The program and proposed integrations could produce $15 million in savings annually.